5-FU	5-Fluorouracil
ADGRV1	adhesion g protein-coupled receptor V1
ALB	albumin
AFP	alpha-fetoprotein
APOB	apolipoprotein B
APOE	apolipoprotein E
ARID1A	AT-rich interaction domain 1A
ARID2	AT-rich interaction domain 2
AXIN1	axis inhibition protein 1
BRAF	B-Raf Proto-Oncogenen
BAP1	BRCA1-associated protein 1
BRD7	Bromodomain-containing 7
CA 19-9	carbohydrate antigen 19-9
CEA	carcinoembryonic antigen
CTNNB1	catenin beta-1
CC	cholangiocarcinoma
cHCC-CC	combined hepatocellular cholangiocarcinoma
CR	complete response
CNVs	copy number variants
DCR	disease control rate
DST	dystonin
EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit
EPCAM	epithelial cell adhesion molecule
FGFR2	fibroblast growth factor receptor 2
FRY	FRY microtubule binding protein
GPC3	glypican 3
HMCN1	hemicentin 1
HCC	hepatocellular carcinoma
HER2/ERBB2	human epidermal growth factor receptor 2/erb-b2 receptor tyrosine kinase 2
IDH	isocitrate Dehydrogenase (NADP(+))
KEAP1	kelch-like ECH-associated protein 1
KRT19	keratin 19
KRAS	kirsten rat sarcoma virus
KMT2D	lysin-Methyltransferase 2D
ML	machine learning
MTOR	mechanistic Target of Rapamycin
MET	MET proto oncogene
MUC2	mucin 2
NEB	nebulin
ORR	overall response rate
OS	overall survival
PR	partial response
PTEN	phosphatase and tensin homologue
PBRM1	polybromo 1
PD-L1	programmed cell death ligand 1
PFS	Progression-free survival
PRDM5	PR/SET domain 5
RFA	radiofrequency ablation
RB1	retinoblastoma protein Transcriptional compressor 1
RPS6KA3	ribosomal protein S6 kinase A3
SIRT	selective internal radiation therapy
SALL4	spalt-like transcription factor 4
SYNE1/2	spectrin repeat containing nuclear envelope protein ½
SWI/SNF	switch/sucrose non-fermentable
SYCP2	synaptonemal complex protein 2
TERT	telomerase-Reverse-Transcriptase
TACE	transarterial chemoembolization
TP53	tumor protein p53
TKI	tyrosine kinase inhibitors
WHO	World Health Organization